Health Care Policy in a Divided Government: What Comes Next

Nov
17
2026

Date: November 17, 2026

Time: 1:00PM - 2:00PM (EST)

With the shifting balance of power in Washington, DC, health care organizations face a changing policy and regulatory landscape. During this webinar, Mintz and ML Strategies will explore how the divided government is likely to shape the health care agenda, including the priorities of the House and Senate majorities and the Trump administration, the key congressional leaders and committees to watch, and how turnover is changing the dynamics on Capitol Hill.

 

Discussion topics will include: 

  • Drug pricing, pharmacy benefit managers (PBMs), and the 340B program

  • Health care affordability, health plans, and changes to the Affordable Care Act (ACA)

  • Medtech and life sciences, including the drug supply chain

  • Women's health under the 120th US Congress

  • Must-pass legislation, such as FDA user fee bills

Who should attend: Health care and life sciences executives, in-house counsel, government affairs professionals, investors, and others who need to understand how a divided government will affect health care policy, regulation, and legislation.

 

Attendees will leave with a clearer picture of the Democrat and Trump administration priorities driving the health care agenda, the players and committees that will shape it, and the legislative opportunities and risks ahead.

Register for Event

Professionals

  • Alexander Hecht
  • Theresa C. Carnegie
  • Anthony M. DeMaio
  • Traci L. Vitek

    • Related Industries

  • Health Care

    • Speakers

    Alexander Hecht

    Alexander Hecht

    Alexander Hecht is Executive Vice President & Director of Operations of ML Strategies in Washington, DC. He has over a decade of senior-level experience in Congress and trade associations. Alex helps clients with regulatory and legislative issues, including health care and technology.
    Theresa C. Carnegie

    Theresa C. Carnegie

    Theresa C. Carnegie is a Member at Mintz who advises clients on all aspects of the pharmaceutical supply chain, including counseling industry stakeholders on a range of business, legal, transactional, and compliance matters. She provides clients with strategic counseling and creative business modeling that considers legal restrictions and regulatory risk in light of innovation and business goals.
    Anthony M. DeMaio

    Anthony M. DeMaio

    Anthony M. DeMaio, Senior Vice President of ML Strategies, draws on over a decade of experience in government affairs and communications — working with members of the Massachusetts congressional delegation — to lobby on behalf of a variety of clients and assist them with congressional investigations and media messaging.
    Traci L. Vitek

    Traci L. Vitek

    Traci L. Vitek, Senior Vice President at ML Strategies in Washington, DC, advises clients on federal health care policy, legislative strategy, and executive branch engagement.